香雷糖足膏 | China Drugs ListXianglei Tangzu Ointment | China Drugs List
本页为公开参考信息，不构成医疗建议、处方或药品供应要约。请向持证专业人士确认当前批准情况、可获得性及适用性。
- 企业
- 合一生技股份有限公司Oneness Biotech Co., Ltd.
- 药品类型
- 中成药Traditional Chinese medicine
- 治疗领域
- 内分泌与代谢Endocrinology & metabolism
- 公开来源记录的适应症
- 本品适用于清创后创面截面积小于 25cm2 的 Wagner 1 级糖尿病足部伤口溃疡。 本品基于早期临床试验数据获得附条件批准上市,有效性和安全性尚待上市后进一步确证。For Wagner grade 1 diabetic foot ulcers with a wound surface area of less than 25 cm2 after debridement. Conditional approval was based on early clinical trial data; efficacy and safety require further confirmation after marketing.
- 适应症来源与口径
- 来源日期： 2025, 2026. 适应症转录自国家医保局公开的企业申报资料；不代表已核实完整的现行说明书。Source date(s): 2025, 2026. Indications transcribed from the public NHSA manufacturer submission; this is not verification of the complete current label.
- 说明书信息局限
- 适应症已与官方公开申报资料核对。尚未取得完整原始说明书。Indications checked against an official public submission. The full original prescribing information is still unavailable.
- 中国可获得性状态
- 已核实中国历史批准记录；尚未逐项核查每个产品目前是否持续上市销售。Historical Chinese approval verified; current continuous market availability has not been checked for every product.
- 海外状态
- 待逐一核查各市场。Market-by-market verification pending.
- 医保分类
- 2025国家医保目录未匹配；待人工复核Not matched in the 2025 national list; manual review pending
- 医保版本
- 2025版；2026年1月1日起执行2025 edition; effective 1 January 2026
- 医保核查说明
- 未在提取的目录中匹配到，并不证明被排除。复方制剂仍需人工复核。No match in the extracted directory is not proof of exclusion. Compound formulations still require manual review.